NCT02180711 2025-10-15Study of Acalabrutinib Alone or in Combination Therapy in Subjects With B-cell Non-Hodgkin LymphomaAcerta Pharma BVPhase 1/2 Active not recruiting113 enrolled 19 charts
NCT04402138 2025-05-13Treatment With Acalabrutinib Post Blood or Marrow Transplantation in Subjects With Mantle Cell LymphomaSCRI Development Innovations, LLCPhase 2 Completed15 enrolled 10 charts